Genetic Counselling Working Group

Date: Friday 18 October 2019
Time: 10:30 – 12:30
Chairs: Sonia Kupfer (USA), Kirsi Pylvänäinen (Finland)

Time Session
10:30 – 10:45 Introduction by chairs
10:45 – 11:05 Non-Uptake of genetic counselling for patients with suspected Lynch syndrome identified ba reflex testing: Half due to non-referral and half due to non-uptake – Zohar Levi (Israel)
11:05 – 11:25 The uptake of predictive DNA-testing in 40 BRCA1/ BRCA2mutation-positive families. An evaluation of the standard proband-mediated procedure – Fred Menko (The Netherlands)
11:25 – 11:45 The public favours healthcare-mediated disclosure of hereditary CRC risk: A population-based survey in Sweden – Anna Rosén (Sweden)
11:45 – 11:55 Risk of contralateral breast cancer in women with and without pathogenic variants in BRCA1, BRCA2 and TP53 genes in women with very early onset – D. Gareth Evans (UK)
11:55 – 12:05 No actionable colorectal cancer risk increase in Dutch proven non-carriers of the predisposition for Lynch syndrome – Rein Stulp (The Netherlands)
12:05 – 12:25 What helps Lynch syndrome patients to cope with consequences of genetic diagnosis of LS. Results of a semi-structured interview – Atalia Tuval (Israel)
12:25 – 12:30 Closing remarks
Top